Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
49,119,839
-
Shares change
-
+189,168
-
Total reported value, excl. options
-
$6,088,356,127
-
Value change
-
+$19,061,884
-
Put/Call ratio
-
137%
-
Number of buys
-
113
-
Number of sells
-
71
-
Price
-
$123.95
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2019
As of 30 Jun 2019 BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) had 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 49,119,839 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, HILLHOUSE CAPITAL ADVISORS, LTD., Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, Temasek Holdings (Private) Ltd, BlackRock Inc., VANGUARD GROUP INC, HILLHOUSE CAPITAL MANAGEMENT, LTD., and PRIMECAP MANAGEMENT CO/CA/.
This table shows 196 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.